American Lawyer and Writer Mysteriously Died in Sleep on Flight to UK

(NationalFreedomPress.com) – A 44-year-old American lawyer died mid-flight to London in what a UK coroner ruled “misadventure,” revealing a deadly combination of undiagnosed heart defect and prescription medications that raises troubling questions about modern medicine’s reliance on pharmaceuticals without adequate screening.

Story Overview

Rachel Green, Minnesota lawyer and writer, died instantly on Delta flight after falling asleep on her mother’s shoulder in April 2025
UK inquest ruled death resulted from undiagnosed myocardial tunnelling combined with antidepressants and melatonin
Coroner classified death as “misadventure” – unintentional consequences of voluntarily taking prescribed medications
Case highlights risks of pharmaceutical interactions with undetected cardiac conditions on long-haul flights

Tragic Death Unfolds at 35,000 Feet

Rachel Green boarded Delta flight DL67 from Minneapolis-Saint Paul to London Heathrow on April 30, 2025, traveling with her mother for what should have been a routine transatlantic journey. Mid-flight, Green fell asleep resting on her mother’s shoulder. When cabin crew attempted to rouse her for meal service, she remained unresponsive. Flight attendants issued an emergency announcement requesting medical assistance. An onboard doctor responded immediately but could not revive the 44-year-old professional. Despite following established emergency protocols, crew and medical responders pronounced Green dead before the aircraft reached British airspace.

UK Inquest Reveals Lethal Medical Combination

West London Coroner’s Court convened an inquest in January 2026 under UK jurisdiction, as required for sudden deaths on flights landing at Heathrow. Senior Coroner Lydia Brown presided over proceedings that examined autopsy findings and medical evidence. Pathologists identified myocardial tunnelling, a congenital heart condition where coronary arteries run beneath heart muscle rather than on the surface. This previously undiagnosed anomaly proved fatal when combined with prescribed antidepressants and melatonin Green had taken. Medical examiners emphasized no excessive dosages were consumed, yet the interaction created instantaneous cardiac failure at altitude.

Misadventure Ruling Clears External Factors

The coroner’s “misadventure” verdict indicates death resulted from unintended consequences of voluntary actions—specifically, taking legally prescribed medications without knowledge of the underlying heart defect. This classification absolved Delta Air Lines of liability and confirmed cabin crew followed proper emergency response procedures. The ruling emphasized no negligence or external contributions caused Green’s death. For families navigating grief, this legal determination provides procedural closure but raises broader concerns about pharmaceutical prescriptions issued without comprehensive cardiac screening, particularly for patients planning air travel where cabin pressure and reduced oxygen levels stress cardiovascular systems.

Broader Implications for Medical Screening

In-flight deaths remain statistically rare, occurring in approximately one in five to ten million passengers, typically involving pre-existing conditions exacerbated by flight environment factors. This case spotlights potential gaps in preventive medicine: Green had no prior symptoms indicating cardiac abnormalities, yet the combination of common prescriptions and an undetected structural heart defect proved immediately fatal. The eight-hour transatlantic flight environment—characterized by lower cabin oxygen levels and prolonged immobility—can trigger cardiac stress in vulnerable individuals. Aviation medical experts acknowledge current screening protocols focus primarily on communicable diseases and obvious health risks rather than hidden congenital conditions.

Family Seeks Answers Beyond Legal Findings

Green’s mother witnessed the tragedy firsthand, while family members including sister Roxanne Carney have grappled with sudden loss. The UK inquest process, designed to establish factual cause of death without assigning blame, leaves open possibilities for separate inquiries into prior medical care in the United States. While the coroner cleared all external parties, families may question whether prescribing physicians conducted adequate cardiovascular evaluations before authorizing medications known to affect heart function. Minnesota’s legal and writing communities mourned the loss of a respected professional whose death underscores how modern pharmaceutical reliance can mask underlying vulnerabilities until catastrophic interactions occur at the worst possible moments.